<p>The US Food and Drug Administration has approved updated COVID-19 vaccines made by Pfizer and Moderna targeting newer variants of the disease in time for a fall vaccination campaign, the agency said on Thursday.</p><p>The US health regulator has approved the vaccines to target a variant known as "KP.2", which dominated infections in recent months. It had asked manufacturers in June to target the strain.</p>.WHO calls for providing lifesaving vaccines to all kids, protecting adolescent girls from cervical cancer.<p>"Vaccination continues to be the cornerstone of COVID-19 prevention," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.</p><p>The FDA granted emergency use authorization for Moderna's shot, branded as Spikevax, and Pfizer and BioNTech shot branded as Comirnaty.</p>
<p>The US Food and Drug Administration has approved updated COVID-19 vaccines made by Pfizer and Moderna targeting newer variants of the disease in time for a fall vaccination campaign, the agency said on Thursday.</p><p>The US health regulator has approved the vaccines to target a variant known as "KP.2", which dominated infections in recent months. It had asked manufacturers in June to target the strain.</p>.WHO calls for providing lifesaving vaccines to all kids, protecting adolescent girls from cervical cancer.<p>"Vaccination continues to be the cornerstone of COVID-19 prevention," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.</p><p>The FDA granted emergency use authorization for Moderna's shot, branded as Spikevax, and Pfizer and BioNTech shot branded as Comirnaty.</p>